button bars forest bayes pooled summary circles
 
deaths (OS)

mML - L2 - all population metastatic/adv melanoma (mML) mML - 2nd line (L2) mML - L2 - all population

versus gp100
ipilimumab plus gp100 vs. gp100 1 certainty unassessablestatistically conclusive-29%
versus ipilimumab alone
ipilimumab plus gp100 vs. ipilimumab alone 1 certainty unassessable+4%

mML - L2 - BRAF mutant metastatic/adv melanoma (mML) mML - 2nd line (L2) mML - L2 - BRAF mutant

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons